Biography

Dr. Renato Mantegazza has a long-lasting experience in the field of Myasthenia Gravis (MG), Neuromuscular Junction Diseases (such as Lambert-Eaton Myasthenic Syndrome), Multiple Sclerosis and Inflammatory Myopathies by giving contributions in the understanding of the pathogenic mechanisms underlying these diseases and in their treatments. Dr. Mantegazza professional and scientific training has been developed at the Weizmann Institute of Science (Israel), Stanford University (USA). His scientific production consists of more than 190 peer-reviewed publications.
He is the Director of the Neuroimmunology and Neuromuscular Diseases Department at the Fondazione Istituto Neurologico "Carlo Besta" of Milan, the largest Italian Institution devoted to clinical and experimental neurosciences. The Neuroimmunology and Neuromuscular Diseases Department is dedicated to diagnostics, treatment and research of immune-mediated neurological diseases as well as neuromuscular/muscular disorders. It comprises a Therapeutic Hemapheretic Service, Diagnostic laboratories for Autoimmunity and Genetics, a Muscle Biopsy Unit and the Multiple Sclerosis Center. The Department also hosts biobanks for sera/plasma, muscle/myoblasts, thymus/thymic cell lines, peripheral blood mononuclear cells, fibroblasts, and nucleic acids from about 4500 patients affected by genetics, autoimmune, inflammatory diseases of the central and peripheral nervous system. Dr. Mantegazza has been recently appointed as the Director of the Clinical Research Department of the Istituto Neurologico "Carlo Besta" and acts himself as PI of several clinical trials in Multiple Sclerosis and Myasthenia Gravis. Dr. Renato Mantegazza is active in Scientific Advisory Boards of Biomarin, Alexion Pharmaceuticals, ARGX Pharma and TEVA Italia